Clinical trial
A Phase II Study of IL-18 in Melanoma Patients
NCT00107718 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of IL-18 in Melanoma Patients
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 15, 2004
- Completion date
- May 19, 2006
- Enrollment
- 64 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.